Sunday, November 4, 2012

Smith & Nephew Management Discusses Q3 2012 Results - Earnings Call Transcript

Seeking Alpha (exerpts related to the hip business)

Excluding BHR, Hip Implant growth was flat on last year, which was an improvement on the last quarter. This compares to total hip market, which was similarly flat. We continue to achieve very good growth in our product forecast, such as ANTHOLOGY systems, OXINIUM surface, POLARCUP and SMF system. The negative commentary on stem metal-on-metal total hip continued and sales of our BHR system were down by 36%. Finally, the full U.S. launch of our new REDAPT Revision Hip System, which significantly improves our hip provision product offering, is on track for later this quarter

(This was one of the last hips that issued a warning to the market on their hip.)

No comments:

Post a Comment